Qualitative and Quantitative Characteristics of the Electroencephalogram in Normal Horses during Administration of Inhaled Anesthesia

BACKGROUND

The effects of anesthesia on the equine electroencephalogram (EEG) after administration of various drugs for sedation, induction, and maintenance are known, but not that the effect of inhaled anesthetics alone for EEG recording.

OBJECTIVE

To determine the effects of isoflurane and halothane, administered as single agents at multiple levels, on the EEG and quantitative EEG (qEEG) of normal horses.

ANIMALS

Six healthy horses.

METHODS

Prospective study. Digital EEG with video and quantitative EEG (qEEG) were recorded after the administration of one of the 2 anesthetics, isoflurane or halothane, at 3 alveolar doses (1.2, 1.4 and 1.6 MAC). Segments of EEG during controlled ventilation (CV), spontaneous ventilation (SV), and with peroneal nerve stimulation (ST) at each MAC multiple for each anesthetic were selected, analyzed, and compared. Multiple non-EEG measurements were also recorded.

RESULTS

Specific raw EEG findings were indicative of changes in the depth of anesthesia. However, there was considerable variability in EEG between horses at identical MAC multiples/conditions and within individual horses over segments of a given epoch. Statistical significance for qEEG variables differed between anesthetics with bispectral index (BIS) CV MAC and 95% spectral edge frequency (SEF95) SV MAC differences in isoflurane only and median frequency (MED) differences in SV MAC with halothane only.

CONCLUSIONS AND CLINICAL IMPORTANCE

Unprocessed EEG features (background and transients) appear to be beneficial for monitoring the depth of a particular anesthetic, but offer little advantage over the use of changes in mean arterial pressure for this purpose.

Electroencephalogram of Healthy Horses During Inhaled Anesthesia

Background

Previous study of the diagnostic validity of electroencephalography (EEG) to detect abnormalities in equine cerebral cortical function relied on the administration of various drugs for sedation, induction, and maintenance of general anesthesia but used identical criteria to interpret recordings.

Objectives

To determine the effects of 2 inhalation anesthetics on the EEG of healthy horses.

Animals

Six healthy horses.

Methods

Prospective study. After the sole administration of one of either isoflurane or halothane at 1.2, 1.4, and 1.6 times the minimum alveolar concentration, EEG was recorded during controlled ventilation, spontaneous ventilation, and nerve stimulation.

Results

Burst suppression was observed with isoflurane, along with EEG events that resembled epileptiform discharges. Halothane results were variable between horses, with epileptiform‐like discharges and bursts of theta, alpha, and beta recorded intermittently. One horse died and 2 were euthanized as the result of anesthesia‐related complications.

Conclusions and Clinical Importance

The results of this study indicate that the effects of halothane and isoflurane on EEG activity in the normal horse can be quite variable, even when used in the absence of other drugs. It is recommended that equine EEG be performed without the use of these inhalation anesthetics and that general anesthesia be induced and maintained by other contemporary means.

Loss of the potassium channel beta-subunit gene, KCNAB2, is associated with epilepsy in patients with 1p36 deletion syndrome

PURPOSE

Clinical features associated with chromosome 1p36 deletion include characteristic craniofacial abnormalities, mental retardation, and epilepsy. The presence and severity of specific phenotypic features are likely to be correlated with loss of a distinct complement of genes in each patient. We hypothesize that hemizygous deletion of one, or a few, critical gene(s) controlling neuronal excitability is associated with the epilepsy phenotype. Because ion channels are important determinants of seizure susceptibility and the voltage-gated K(+) channel beta-subunit gene, KCNAB2, has been localized to 1p36, we propose that deletion of this gene may be associated with the epilepsy phenotype.

METHODS

Twenty-four patients were evaluated by fluorescence in situ hybridization with a probe containing KCNAB2. Clinical details were obtained by neurologic examination and EEG.

RESULTS

Nine patients are deleted for the KCNAB2 locus, and eight (89%) of these have epilepsy or epileptiform activity on EEG. The majority of patients have a severe seizure phenotype, including infantile spasms. In contrast, of those not deleted for KCNAB2, only 27% have chronic seizures, and none had infantile spasms.

CONCLUSIONS

Lack of the beta subunit would be predicted to reduce K(+) channel-mediated membrane repolarization and increase neuronal excitability, suggesting a possible relation between loss of this gene and the development of seizures. Because some patients with seizures were not deleted for KCNAB2, there may be additional genes within 1p36 that contribute to epilepsy in this syndrome. Hemizygosity of this gene in a majority of monosomy 1p36 syndrome patients with epilepsy suggests that haploinsufficiency for KCNAB2 is a significant risk factor for epilepsy.

Haloperidol-induced tardive dyskinesia in a child with Gilles de la Tourette's disease

A 7-year-old boy with multiple tic or Gilles de la Tourette's disease was treated with haloperidol. Within five months, lingual-buccal-facial movements developed that were characteristic of tardive dyskinesia. This new movement disorder disappeared after treatment with haloperidol was stopped. To our knowledge, this is the first report of tardive dyskinesia complicating the use of haloperidol in the treatment of multiple tic syndrome in a child.

[The prognostic value of the E.E.G. in premature infants (author's transl)]

The electroencephalograms of 82 infants (between 27 and 37 weeks of conceptional age) recorded during the neonatal period were analyzed and compared with the ultimate clinical evolution. Three groups of infants were identified according to their neurological state at 3 years of age or older: group A: normal (34 infants), group B: minor neurological sequellae (13 infants) and group C: major neurological sequellae (17 infants). A fourth group (group D: 18 infants) died during the neonatal period. The E.E.Gs were classified as: normal, questionably abnormal, moderately abnormal or grossly abnormal. The analysis revealed that E.E.Gs classified as grossly abnormal, were found only in groups B, C and D. Serial E.E.Gs were of more value in distinguishing these groups. Only infants in groups C and D (with I exceptional case in group B) had E.E.Gs which remained abnormal for several weeks or which deteriorated during the neonatal period. This study shows the prognostic value of the E.E.G. recorded during the neonatal period, particularly serial recordings obtained during and after a period of clinical deterioration. A detailed statistical analysis of the E.E.Gs is in progress.

[The normal E.E.G. of the neonate (author's transl)]

This study is the statement of the present knowledge of the normal EEG activity of the full term and the premature neonates. The criteria for normality of the records are based on transversal studies of normal newborn babies, born after a normal pregnancy and a normal delivery (Apgar 9 and 10). Follow up studies of children over of period of 3 years or more have allowed to appreciate the variability of the neonatal EEG, especially in premature babies having a later normal psycho-motor development. The variability of bioelectric activity is considerable from child to child and in the same child from one moment to another especially during quiet sleep. EEG activity varies according to the states of vigilance and sleep. Organisation of sleep is independent of the recording methods, as shown by a comparative study using different technics of electrode application.